JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Talbot, P. S.
Right arrow Articles by Hwang, D.-R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Talbot, P. S.
Right arrow Articles by Hwang, D.-R.
Journal of Nuclear Medicine Vol. 46 No. 3 484-494
© 2005 by Society of Nuclear Medicine


Basic Science Investigations

11C-GR103545, a Radiotracer for Imaging{kappa}-Opioid Receptors In Vivo with PET: Synthesis and Evaluation in Baboons

Peter S. Talbot, MD1, Raj Narendran, MD1, Eduardo R. Butelman, PhD2, Yiyun Huang, PhD1,3, Kim Ngo, BS1, Mark Slifstein, PhD1, Diana Martinez, MD1, Marc Laruelle, MD1,3 and Dah-Ren Hwang, PhD1

1 Department of Psychiatry, Columbia University College of Physicians and Surgeons and the New York State Psychiatric Institute, New York, New York
2 Laboratory on the Biology of Addictive Diseases, Rockefeller University, New York, New York
3 Department of Radiology, Columbia University College of Physicians and Surgeons and the New York State Psychiatric Institute, New York, New York

Brain {kappa}-opioid receptors (ORs) may be involved in several pathologic conditions, such as addiction, psychosis, and seizures. (±)-4-Methoxycarbonyl-2-[(1-pyrrolidinylmethyl]-1-[(3,4-dichlorophenyl)acetyl]-piperidine (GR89696) is a potent and selective {kappa}-OR agonist. The (–)-isomer, GR103545, is the active enantiomer of GR89696. The aim of this study was to characterize the potential of 11C-GR103545 to image {kappa}-OR in vivo with PET. Methods: Brain uptake of 11C-GR103545 was studied in baboons under control conditions and after blockade by naloxone (1 mg/kg intravenously). Uptake of the racemic 11C-GR89696 and of the inactive enantiomer (+)-11C-GR89696 was also evaluated. Regional total distribution volumes were derived using the arterial input function and a 2-tissue-compartment model. Results: 11C-GR103545 showed excellent brain penetration and uptake kinetics, with significant washout observed within the time frame of the PET experiment. Naloxone pretreatment did not affect cerebellar total distribution volume and reduced total distribution volume in other regions to a level comparable to that in the cerebellum. The regional pattern of 11C-GR103545 binding potential was consistent with the distribution of {kappa}-OR in primate brain, with highest levels observed in anterior cortical regions (prefrontal cortex and cingulate cortex) and striatum. In most regions, the specific-to-nonspecific equilibrium partition coefficient (V3'') ranged from 1 to 2, predicting reliable quantification. 11C-GR103545 V3'' values were approximately double the 11C-GR89696 V3'' values, whereas (+)-11C-GR89696 V3'' values were negligible, demonstrating the enantiomeric selectivity of the binding and the advantage of using the pure active enantiomer for PET studies. Conclusion: 11C-GR103545 is a promising PET radiotracer for imaging the {kappa}-OR.

Key Words: {kappa}-opioid receptor • (–)- 11C-4-methoxycarbonyl-2-[(1-pyrrolidinylmethyl]-1-[(3,4-dichlorophenyl)acetyl]-piperidine • PET • baboon




This article has been cited by other articles:


Home page
BrainHome page
G. Henriksen and F. Willoch
Imaging of opioid receptors in the central nervous system
Brain, May 1, 2008; 131(5): 1171 - 1196.
[Abstract] [Full Text] [PDF]


Home page
J. Neuropsychiatry Clin. Neurosi.Home page
M. Martin, R. A. Hurley, and K. H. Taber
Is Opiate Addiction Associated With Longstanding Neurobiological Changes?
J Neuropsychiatry Clin Neurosci, August 1, 2007; 19(3): 242 - 248.
[Full Text] [PDF]


Home page
JNMHome page
H.-J. Machulla and A. Heinz
Radioligands for Brain Imaging of the {kappa}-Opioid System
J. Nucl. Med., March 1, 2005; 46(3): 386 - 387.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 2005 by the Society of Nuclear Medicine.